Database from Empirical Evidence of Drug Pricing Games - A Citizen's Pathway Gone Astray
688 Pages Posted: 7 Mar 2017
Date Written: September 1, 2016
This document contains the underlying data for the study presented in Empirical Evidence of Drug Pricing Games - A Citizen’s Pathway Gone Astray, available at https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2833151.
We are making all of the data publicly available on SSRN for future use by other academics, in accordance with the protocols outlined in the Open Letter on Ethical Norms, published in the Harvard Journal of Law and Technology.
Other academics are free to use the database, but only with proper author attribution, along with a link to the original database in any derivative work, subsequent publication, or data set that incorporates our work.
The data is organized into the following four sections: 1. Summary Metrics (beginning on page 3) 2. Delay-Related Citizen Petitions with Linked Generic Applications and Timing Information, 2000-2012 (beginning on page 5) 3. All Generic Applications Approved Between 2006 and 2015 (beginning on page 15) 4. All Pharma-Related Citizen Petition Filings Posted Between 2000 and 2015 (beginning on page 184)
We have made slight modifications to the database to make it possible to upload the data to SSRN in readable form. To request the Excel version or to inquire about additional data that was assembled, please contact Professor Robin Feldman, email@example.com.
Keywords: patent, pharmaceutical, pharmaceuticals, citizen petitions, Hatch-Waxman, FDA, drug prices, antitrust, drug pricing, health, data, dataset, data set, database
Suggested Citation: Suggested Citation